REBECCA ROBBINS: Open Payments
NPI 1083786263 · DALLASTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,688 in 87 payments from 20 companies in 2025. Trend: 2023 $1,396 · 2024 $1,588 · 2025 $1,688
Food & beverage: $1,539Education: $149
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $253 |
| Astellas Pharma US Inc | 5 | $218 |
| Novo Nordisk Inc | 10 | $214 |
| ABBVIE INC. | 11 | $197 |
| AstraZeneca Pharmaceuticals LP | 10 | $193 |
| Lilly USA, LLC | 7 | $130 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $48 |
Products named: NURTEC ODT, AIRSUPRA, VRAYLAR, MOUNJARO, Ozempic, Wegovy, Veozah, UBRELVY.
Industry payments across PA — which companies pay providers there.
